Yuyu Pharma, Inc.

KOSE:A000220 Voorraadrapport

Marktkapitalisatie: ₩73.8b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Yuyu Pharma Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Robert Yu

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO4.5yrs
Eigendom CEO26.5%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance

Aug 24
Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance

Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now

Aug 07
Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now

Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden

Apr 02
Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden

Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?

Mar 08
Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?

The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More

Feb 10
The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More

We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide

Jan 07
We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide

Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly

Dec 20
Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly

Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?

Dec 03
Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?

CEO

Robert Yu

4.5yrs

Tenure

Mr. Wonsang Yu, also known as Robert, has been President and Chief Executive Officer of Yuyu Pharma, Inc. since April 6, 2020 and served as its Vice President. Prior to joining Yuyu Pharma in 2008, Mr. Yu...